<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00137579</url>
  </required_header>
  <id_info>
    <org_study_id>SINGRIP03</org_study_id>
    <nct_id>NCT00137579</nct_id>
  </id_info>
  <brief_title>Safety of the Intramuscular Route of the Anti-Flu Vaccine in Patients Receiving Oral Anticoagulation Therapy</brief_title>
  <official_title>Phase IV, Simple Blind, 2-Parallel Groups Randomized Trial to Evaluate the Safety and Effectiveness of the Intramuscular Vs Subcutaneous Route for the Administration of the Anti-Flu Vaccine in Patients Receiving Oral Anticoagulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Catalan Institute of Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Catalan Institute of Health</source>
  <brief_summary>
    <textblock>
      Until now, the best administration route of the anti-flu vaccine for patients receiving long&#xD;
      term oral anticoagulation therapy has been the subcutaneous one; the intramuscular route has&#xD;
      not been recommended because it may increase the risk of muscular haematoma. Although this&#xD;
      practice is widely extended, no significant differences between the safety of both routes&#xD;
      have been found. Some authors, analysing a small group of patients, affirm that the anti-flu&#xD;
      vaccine can be administered safely by the intramuscular route on patients receiving long term&#xD;
      oral anticoagulation therapy, while a previous opinion article recommended the subcutaneous&#xD;
      route without any scientific evidence. Due to this, the investigators have done a clinical&#xD;
      trial with the aim of determining the safety and effectiveness of the flu-vaccine&#xD;
      intramuscular route in patients receiving long term oral anticoagulation therapy and also to&#xD;
      analyse the possible interactions between the vaccine and the oral anticoagulant treatment.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Phase IV, simple blind, 2-parallel groups, multicentric randomized trial where each patient&#xD;
      will receive a single dose of the recommended by the WHO anti-flu vaccine for the 2003-2004&#xD;
      period, the control group will receive it subcutaneous and intervention group intramuscular.&#xD;
      The assignation to each group will be randomized. The study included 4 basic areas of&#xD;
      Barcelona city. Three visits have been scheduled for each patient: moment 0, 24 hours and 10&#xD;
      days after the vaccination, and a 7 month follow up period to control the incidence of the&#xD;
      flu.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2003</start_date>
  <completion_date>May 2004</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single</masking>
  </study_design_info>
  <primary_outcome>
    <measure>local pain (scores greater than 3 in the analogic visual scale of pain)</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>microbiologically diagnosed flu (yes/no)</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>International Normalized Ratio (INR) to check the interaction between the vaccine and the oral anticoagulation therapy</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>increase of the arm perimeter greater than 1 cm</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>local elemental skin lesions</measure>
  </secondary_outcome>
  <enrollment>216</enrollment>
  <condition>Influenza</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Influenza vaccine intramuscular administration route</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with oral anticoagulation therapy&#xD;
&#xD;
          -  Patients who agree to be vaccinated&#xD;
&#xD;
          -  Patients who agree to participate in the study&#xD;
&#xD;
          -  Patients older than 18&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Allergy or hypersensibility to egg, chicken proteins, any component of the vaccine&#xD;
             (neomycin, octoxinol-9 or formaldehyd)&#xD;
&#xD;
          -  INR greater than 4 in the past 2 months&#xD;
&#xD;
          -  Previous major bleeding&#xD;
&#xD;
          -  Patients with dementia or with legal tutoring&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Josep Casajuana, Physician</last_name>
    <role>Principal Investigator</role>
    <affiliation>Catalan Institute of Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Elvira Givert, Nurse</last_name>
    <role>Study Chair</role>
    <affiliation>Catalan Institute of Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Josep Franch, Physician</last_name>
    <role>Study Chair</role>
    <affiliation>Catalan Institute of Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Clara Sala, Nurse</last_name>
    <role>Study Chair</role>
    <affiliation>Catalan Institute of Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Miriam Aballi, Physician</last_name>
    <role>Study Chair</role>
    <affiliation>Catalan Institute of Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Begoña Iglesias, Physician</last_name>
    <role>Study Chair</role>
    <affiliation>Catalan Institute of Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Joan Antoni Valles, Physician</last_name>
    <role>Study Chair</role>
    <affiliation>Catalan Institute of Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maria del Mar Piqueras, Physician</last_name>
    <role>Study Chair</role>
    <affiliation>Catalan Institute of Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paz Escobar, Nurse</last_name>
    <role>Study Chair</role>
    <affiliation>Catalan Institute of Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antonia Moreno, Nurse</last_name>
    <role>Study Chair</role>
    <affiliation>Catalan Institute of Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Montserrat Català, Nurse</last_name>
    <role>Study Chair</role>
    <affiliation>Catalan Institute of Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anna Maria Ramirez, Nurse</last_name>
    <role>Study Chair</role>
    <affiliation>Catalan Institute of Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maria Queralt Capdevila, Nurse</last_name>
    <role>Study Chair</role>
    <affiliation>Catalan Institute of Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Merce Botinas, Physician</last_name>
    <role>Study Chair</role>
    <affiliation>Catalan Institute of Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lilia Villagrassa, Nurse</last_name>
    <role>Study Chair</role>
    <affiliation>Catalan Institute of Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Josep Maria Segura, Physician</last_name>
    <role>Study Chair</role>
    <affiliation>Catalan Institute of Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maria del Mar Ballester, Physician</last_name>
    <role>Study Chair</role>
    <affiliation>Catalan Institute of Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gustavo Losada, Physician</last_name>
    <role>Study Chair</role>
    <affiliation>Catalan Institute of Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maria Teresa Maudos, Physician</last_name>
    <role>Study Chair</role>
    <affiliation>Catalan Institute of Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Raval Nord</name>
      <address>
        <city>Barcelona</city>
        <zip>08001</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Raval Sud</name>
      <address>
        <city>Barcelona</city>
        <zip>08001</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gotic</name>
      <address>
        <city>Barcelona</city>
        <zip>08002</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Casc Antic</name>
      <address>
        <city>Barcelona</city>
        <zip>08003</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>January 2003</verification_date>
  <study_first_submitted>August 29, 2005</study_first_submitted>
  <study_first_submitted_qc>August 29, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 30, 2005</study_first_posted>
  <last_update_submitted>December 12, 2005</last_update_submitted>
  <last_update_submitted_qc>December 12, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 13, 2005</last_update_posted>
  <keyword>Influenza Vaccines</keyword>
  <keyword>Acenocoumarol</keyword>
  <keyword>Drug Administration Routes</keyword>
  <keyword>Anticoagulants</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Influenza, Human</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

